Hyelim Cho

Hyelim Cho, PhD MBA, currently serves as Senior Director of Business Development and Alliance Management at RayzeBio since November 2024. Prior experience includes a role as Director at Boehringer Ingelheim, where responsibilities encompassed serving as Chief of Staff to the Global Head of Immuno-Oncology, managing research portfolios, and overseeing external alliances from January 2023 to November 2024. Prior roles also include Director at Almirall, Group Lead at Takeda, Senior Scientist at Merck, and Postdoctoral Scientist at Novartis, specializing in immuno-oncology, immune-mediated diseases, and drug discovery. Hyelim holds an MBA from Isenberg School of Management, UMass Amherst, a PhD in Immunology and Virology from Washington University School of Medicine, and a BS in Biology from Korea Advanced Institute of Science and Technology.